MOLECULAR BASIS OF CELL AND DEVELOPMENTAL BIOLOGY
Modulation of Basic Helix-Loop-Helix Transcription Complex Formation by Id Proteins during Neuronal Differentiation*

https://doi.org/10.1074/jbc.M107713200Get rights and content
Under a Creative Commons license
open access

It is assumed that the Id helix-loop-helix (HLH) proteins act by associating with ubiquitously expressed basic HLH (bHLH) transcription factors, such as E47 and E2-2, which prevents these factors from forming functional hetero- or homodimeric DNA binding complexes. Several tissue-specific bHLH proteins, including HASH-1, dHAND, and HES-1, are important for development of the nervous system. Neuroblastoma tumors are derived from the sympathetic nervous system and exhibit neural crest features. In differentiating neuroblastoma cells, HASH-1 is down-regulated, and there is coincident up-regulation of the transcriptional repressor HES-1, which is known to bind the HASH-1 promoter. We found that the three Id proteins expressed in neuroblastoma cells (Id1, Id2, and Id3) were down-regulated during induced differentiation, indicating that Id proteins help keep the tumor cells in an undifferentiated state. Studying interactions, we noted that all four Id proteins could dimerize with E47 or E2-2, but not with HASH-1 or dHAND. However, the Id proteins did complex with HES-1, and increased levels of Id2 reduced the DNA binding activity of HES-1. Furthermore, HES-1 interfered with Id2/E2-2 complex formation. The ability of Id proteins to affect HES-1 activity is of particular interest in neuronal cells, where regulation of HES-1 is essential for the timing of neuronal differentiation.

Cited by (0)

Published, JBC Papers in Press, December 27, 2001, DOI 10.1074/jbc.M107713200

*

This work was supported by grants from the Swedish Cancer Society, the Children's Cancer Foundation of Sweden, Inga and John Hain's Foundation, Åke Wiberg's Foundation, the Crafoord Foundation, HKH Kronprinsessans Lovisas förening för barnasjukvård, Hans von Kantzow's Foundation, and Malmö University Hospital Research Funds.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

These authors contributed equally to this work.

§

Present address: Dept. of Medical Biochemistry and Microbiology, Uppsala University, BMC, P.O. Box 582, S-751 23 Uppsala, Sweden.